Azin Parhizgar To Chair Protembis’ New Board of Directors Leadership team reinforced for next phase in Protembis’ clinical and regulatory growth trajectory Aachen, Germany, September 15, 2022 Protembis GmbH, a privately-held emerging cardiovascular medical device company, announced today the appointment of highly experienced and successful serial entrepreneur and medical device executive Azin Parhizgar (Ph.D.) as … Weiterlesen …
Protembis announces completion of 20 cases in European CE mark study with the ProtEmbo® Cerebral Protection System Enrollment with advanced generation device for complete cerebral protection nearing halfway mark in clinical study in Germany and Poland Aachen, Germany, February 25, 2021 Protembis GmbH, a privately held emerging medical device company, announced today the successful completion … Weiterlesen …
Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing Protembis Develops a Novel Catheter-Based Filter System to Protect Patients Undergoing Interventional Heart Procedures from Stroke and Other Neurological Injuries Aachen, Germany, October 26, 2018 The Managing Directors and founders of Protembis GmbH, Karl von Mangoldt and Conrad Rasmus, have successfully closed a … Weiterlesen …
Protembis Achieves ISO 13485:2016 Quality Management System Certification Protembis GmbH announced today its successful certification in compliance with ISO 13485:2016. ISO 13485:2016 indicates that the Protembis Quality Management System complies with the stringent, international ISO standards for the design and development of medical devices. The certification was provided by BSI Group. Aachen, Germany, January 9, … Weiterlesen …
Protembis announces successful first-in-human use of its ProtEmbo®Cerebral Protection System in European trial Protembis GmbH, a privately held medical device company, announced today the first clinical applications of its ProtEmbo® Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo® System is an intra-aortic filter device that deflects embolic material arising … Weiterlesen …
Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion Company Set to Initiate European First-in-Human Trial with its Novel Cerebral Protection System Aachen, Germany and Cambridge, MA, July 25, 2017 Protembis, a medical device company headquartered in the engineering and technology city of Aachen, Germany, announced today its collaboration with the German … Weiterlesen …
Medical device company Protembis GmbH has closed its seed financing round Led by Innovationsstarter Fonds Hamburg GmbH, Geratherm Medical AG and a group of angel investors, the financing will fund R&D and clinical trials of its novel embolic protection device Hamburg, Germany, July 28, 2015 Hamburg-based startup company Protembis GmbH has successfully closed a seven-digit … Weiterlesen …
Medical device company Protembis GmbH wins state subsidy programme “KMU-innovativ: Medizintechnik” Medical device company Protembis GmbH wins state subsidy programme “KMU-innovativ: Medizintechnik”. Granted by the Federal Ministry of Education and Research (BMBF), the programme supports innovative small and medium-sized enterprises Hamburg, Germany, April 24, 2015 Hamburg-based startup company Protembis GmbH has secured a seven-digit state … Weiterlesen …
